Immune Design CS (IMDZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IMDZ | ZTS | SHPG | NKTR | GRFS |
| Company | Immune Design CS | Zoetis Inc Cl A | Shire Plc Ads | Nektar Therapeutics | Grifols S.A. ADR |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 5.84 | 146.25 | 176.60 | 1.3900 | 6.49 |
| High | 5.85 | 149.70 | 181.22 | 1.4162 | 6.66 |
| Low | 5.84 | 145.18 | 175.71 | 1.3100 | 6.45 |
| Last | 5.85 | 149.30 | 179.20 | 1.3500 | 6.49 |
| Change | unch | +3.76 | +7.05 | -0.0100 | +0.19 |
| % Change | unch | +2.58% | +4.10% | -0.74% | +3.02% |
| Volume | 103,800 | 1,765,774 | 5,316,900 | 391,322 | 1,193,006 |
| 20-Day Average Volume | 409,005 | 4,015,260 | 2,534,020 | 3,753,494 | 1,266,778 |
| Previous Close | 5.85 | 145.54 | 172.15 | 1.3600 | 6.30 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | No | Yes | No | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 5.84 | 159.38 | 172.50 | 1.2504 | 6.71 |
| 20-Day Raw Stochastic | 100.00% | 16.97% | 87.32% | 53.30% | 23.64% |
| 20-Day Relative Strength | 88.63% | 32.23% | 55.84% | 58.80% | 45.20% |
| Weighted Alpha | -20.50 | -21.22 | +17.10 | +32.73 | +0.20 |
| Today's Opinion | 88% Buy | 88% Sell | N/A | 96% Buy | 100% Sell |
| Previous Opinion | 88% Buy | 88% Sell | N/A | 96% Buy | 100% Sell |
| Last Month's Opinion | 56% Buy | 24% Sell | N/A | 88% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 03/25/19 | -2.45% since 04/16/24 | +3.58% since 12/28/18 | -11.07% since 04/16/24 | -3.98% since 04/16/24 |
| Low | 5.84 on 04/01/19 | 144.80 on 04/22/24 | 171.48 on 01/03/19 | 1.2000 on 04/19/24 | 6.25 on 04/22/24 |
| High | 5.85 on 04/01/19 | 153.67 on 04/18/24 | 181.22 on 01/04/19 | 1.5000 on 04/17/24 | 6.84 on 04/17/24 |
| 1-Month | |||||
| %Chg | +0.34% since 03/01/19 | -11.62% since 03/22/24 | +4.49% since 12/04/18 | +45.05% since 03/22/24 | +4.66% since 03/22/24 |
| Low | 5.82 on 03/14/19 | 144.80 on 04/22/24 | 165.29 on 12/18/18 | 0.8400 on 03/27/24 | 6.25 on 04/22/24 |
| High | 5.85 on 04/01/19 | 171.14 on 03/28/24 | 181.22 on 01/04/19 | 1.7500 on 04/11/24 | 7.35 on 04/09/24 |
| 3-Month | |||||
| %Chg | +350.00% since 12/31/18 | -20.64% since 01/23/24 | +1.33% since 10/04/18 | +159.80% since 01/23/24 | -11.43% since 01/23/24 |
| Low | 1.22 on 01/03/19 | 144.80 on 04/22/24 | 165.29 on 12/18/18 | 0.5020 on 01/24/24 | 5.30 on 03/06/24 |
| High | 5.85 on 04/01/19 | 200.53 on 02/29/24 | 182.47 on 11/12/18 | 1.7500 on 04/11/24 | 9.37 on 02/28/24 |
| 6-Month | |||||
| %Chg | +73.08% since 10/01/18 | -10.35% since 10/23/23 | +6.65% since 07/03/18 | +176.39% since 10/23/23 | -17.70% since 10/23/23 |
| Low | 1.10 on 12/24/18 | 144.80 on 04/22/24 | 165.29 on 12/18/18 | 0.4126 on 11/13/23 | 5.30 on 03/06/24 |
| High | 5.85 on 04/01/19 | 201.92 on 12/14/23 | 182.47 on 11/12/18 | 1.7500 on 04/11/24 | 12.15 on 12/29/23 |
| Key Statistics | |||||
| Market Capitalization, $K | 282,935 | 66,564,024 | 54,706,176 | 249,720 | 4,331,628 |
| Shares Outstanding, K | 48,365 | 457,359 | 305,280 | 183,618 | 687,560 |
| Annual Sales | 2,200,000 | 8,544,000,000 | 15,160,600,000 | 90,120,000 | 7,134,500,000 |
| Annual Net Income | -54,760,000 | 2,344,000,000 | 4,271,500,000 | -276,060,000 | 131,340,000 |
| Last Quarter Sales | 480,000 | 2,213,000,000 | 3,871,700,000 | 23,890,000 | 2,025,030,000 |
| Last Quarter Net Income | -13,600,000 | 525,000,000 | 537,200,000 | -42,080,000 | 125,920,000 |
| 60-Month Beta | 3.48 | 0.85 | 0.87 | 0.90 | 0.56 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 1.24 on 02/13/24 | 3.64 on 11/01/18 | -0.22 on 03/04/24 | 0.09 on 07/27/23 |
| Latest Earnings Date | 05/01/19 | 05/02/24 | 02/13/19 | 05/14/24 | 03/05/24 |
| Most Recent Dividend | N/A | 0.432 on 04/18/24 | 0.168 on 09/06/18 | N/A | 0.370 on 06/03/21 |
| Next Ex-Dividends Date | N/A | 04/18/24 | 09/06/18 | N/A | 06/03/21 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 27.54 | 11.21 | 0.00 | 0.00 |